key: cord-0908431-3g7pha20
authors: Zemaitis, L.; Alzbutas, G.; Gecys, D.; Komissarov, A.; Pautienius, A.; Ugenskiene, R.; Sukys, M.; Lesauskaite, V.
title: Determining international spread of novel B.1.1.523 SARS-CoV-2 lineage
date: 2021-11-24
journal: nan
DOI: 10.1101/2021.11.21.21266655
sha: 0480f450566ebb2ac89262269e62e33a81458773
doc_id: 908431
cord_uid: 3g7pha20

Here we report the emergence of variant lineage B.1.1.523 that contains a set of mutations including 156_158del, E484K and S494P in Spike protein. E484K and S494P are known to significantly reduce SARS-CoV-2 neutralization by convalescent and vaccinee sera and are considered as mutations of concern. Lineage B.1.1.523 has presumably originated in Russian Federation and spread across European countries with the peak of transmission in April / May 2021. The B.1.1.523 lineage has now been reported from 27 countries.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.21.21266655 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

A large dataset of SARS-CoV-2 genomes has been collected in the GISAID database, which now 34 contains more than 3.7 million sequenced genomes from around the world 4 . As of May 31, 2021, 35 World Health Organisation (WHO) has proposed designations for global SARS-CoV-2 variants of 36 concern (VOC) and variants of interest (VOI) to be used alongside scientific nomenclature in 37 communications about variants to the public 5 . This list includes the variants on the global list of 38 WHO VOC and VOI and will be updated as the list of WHO changes. There are currently three SARS- 39 CoV-2 VOCs: Beta, Gama and Delta. The variant previously classified as Alpha (B.1.1.7) has been 40 reclassified as de-escalated due to the drastic decrease in prevalence in the EU/EEA 6 . 41 Through the routine analysis of National Lithuanian sequencing results from national With this report we aim to share a detailed analysis of discovered variant, evaluate its origin 53 as well as predict potential epidemiological impact and risks. respectively. These altered residues are found in the NTD 'supersite' that is targeted by most anti-64 NTD neutralizing antibodies, thus providing a mode to dodge immune system 7 . Moreover, E484K 65 mutation also contributes to SARS-CoV-2 immune system evasion. Several recent studies have 66 observed that E484K may significantly reduce convalescent serum neutralization 8,9 . Additionally, it 67 was observed that S494P mutation is related to 3-5-fold reduced SARS-CoV-2 neutralization in sera), 68 however, this mutation was not as potent at neutralization as E484K 8,10 . With a combination of 69 156_158del, E484K, and S494P mutations, B1.1.523 lineage should remain on epidemiologists 70 watchlist as one of the most concerning SARS-CoV-2 lineages. 71 In addition to 156_158del, E484K, and S494P more than 70% of genomes attributed as is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. Transitions E1 (introduction of the triple deletion) and E2 (introduction of E484, S494P) ( Fig.   134 3) indicate a pathway where the majority of B.1.1.523 lineage sequences took. As in the case of data 135 given in (Fig. 3) we do not detect sequential acquisition of E484K or S494P, and immediately next to 136 the triple deletion we see the two aforementioned additional mutations. This could indicate a 137 potential recombination event, but it is most probably due to lack of insufficient data. 138 An interesting case is with two highly diverged Turkey sequences that are classified by Pango 139 as B.1.1.523 lineage. In this case following the most likely scenario at first the E484K was acquired 140 and only then the S494P and E156_R158del were acquired (Fig. 4) . As in the case discussed before, 141 the sequential acquire steps are lacking from the data. Most probably the sequencing data was not 142 comprehensive enough to reveal the full picture on how the combination was formed. In addition, 143 these two highly diverged sequences indicate that there exist vast uncharted territories of COVID- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.21.21266655 doi: medRxiv preprint circulation in Russia or its frequency dropped below the sensitivity threshold of SARS-CoV-2 genomic 225 surveillance in this country. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. notably for the antibodies H11-H4_6ZH9, H11-D4_6YZ5, Sb45_7KGJ, Sb16_7KGK (Fig 10A) . For the 251 most part the most significant antibody escape effect was noticed by the E484K mutation; however, 252 in some cases the S494P effect was also prominent. The largest effect by the S494P mutation was 253 observed for the E_7KN5 12 antibody structure (Fig. 10B) : the S494P mutation increased the binding 254 ΔΔ G by 74 % and the additional effect of E484 mutation was negligible (Fig. 10A) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.21.21266655 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint An in vitro study for SARS-CoV-2 spike protein mutations that are responsible for antibody 287 evasiveness has identified that S494P mutation 15 reduce SARS-CoV-2 neutralization by 3-5-fold in 288 some convalescent sera. However, this mutation was not as potent at neutralization as E484K 16. 289 The results show that S494P mutation increases the spike protein stability. Also, applying docking 290 by HADDOCK displayed higher binding affinity to hACE2 for mutant spike than wild type possibly 291 due to the increased β-strand and turn secondary structures which increases surface accessibly 292 surface area (SASA) and chance of interaction. Currently deposited sequences in GISAID do not 293 support hypothesis that S:156_158del were combined with S:E484K and S:S494P during a 294 recombination event; rather it looks like that initially the triple deletion was introduced and then 295 followed addition of S:E484K and S:S494P. 296 We have showed by molecular modelling that in at least one case of antibody the triple 297 deletion del156-158 could decrease interaction. The combination with other immune escape 298 enhancing mutation at RBD this could result in highly resistant variant to immunity that was formed 299 by the initial virus variants. Delta variant also poses sequence changes at the S protein residues 156-300 158 that can induce immune escape and recombination with the B.1.1.523 variant or de novo 301 introduction of the N484K and S494P mutations could make the Delta variant even more dangerous. 302 The case with Turkey sequences is controversial. The sequences at the S region significantly deviated 303 fragments with many "private" mutations. These sequences have been seen across several 304 submissions; hence, these might be not artificial. If these sequences are not artifacts, then the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.21.21266655 doi: medRxiv preprint 324 Sequences used for the analyses were downloaded from GISAID 18 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.21.21266655 doi: medRxiv preprint 10.1093/bioinformatics/btaa582] using LG substitution model. The sequence alignment that was 362 used to construct the tree was composed from the alignment produced by the Nextclade leaving 363 only the representative sequences of the clusters and CAT approximation with 20 rate categories. 364 lg -gamma". Also command line flags that should increase calculations accuracy were added: "-spr 365 4 -mlacc 2 -slownni -double-precision ". The tree was re-rooted using sequence matching to the 366 EPI_ISL_402124 as an out-group using gotree 0.4.1 [https://anaconda.org/bioconda/gotree/files]. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ; https://doi.org/10.1101/2021.11.21.21266655 doi: medRxiv preprint part "InterfaceRelax2019" script was used. The lowest energy model was chosen from 200 models. 402 The antibody docking was done using the SnugDock program 32 from the Rosetta package, using 403 these non-default flags: "-auto_generate_h3_kink_constraint -h3_loop_csts_hr -h3_filter false -404 docking_centroid_inner_cycles=20 -docking_centroid_outer_cycles=2 ". for each model docking 405 was run 300 times and the top 175 structures based on the interface score were chosen for analysis. 406 Antibody escape effect of E484K and S494P mutations were analysed using is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 24, 2021. ;

A new coronavirus associated with human respiratory disease in China

European Centre for Disease Prevention and Control. How ECDC collects and processes 421 COVID-19 data

disease and diplomacy: GISAID's innovative contribution to global 423 health. Global challenges

European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 427

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing 431 antibodies

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding 433 domain that affect recognition by polyclonal human plasma antibodies

A tale of three SARS-CoV-2 436 variants with independently acquired P681H mutations in New York State

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and 442 suppress mutational escape

Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 446 variants

Covid-19: The E484K mutation and the risks it poses

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum 449 antibody neutralization

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding 451 Domain that Escape Antibody Recognition

Under-reporting of COVID-19 cases in Turkey. The International journal of health 453 planning and management

Euro 455 surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease 456 bulletin 22

Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and 458 B.1.351/501Y-V2

Nextstrain: real-time tracking of pathogen evolution

Some probabilistic and statistical problems in the analysis of DNA sequences

Maximum likelihood estimation of the heterogeneity of substitution 464 rate among nucleotide sites

Inferring putative transmission clusters with Phydelity

An improved general amino acid replacement matrix

Identifying and engineering ancient variants of enzymes using Graphical 470 Representation of Ancestral Sequence Predictions (GRASP)

Using ggtree to Visualize Data on Tree-Like Structures. Current Protocols in 473

PoSeiDon: a Nextflow pipeline for the detection of evolutionary recombination 475 events and positive selection

GARD: a genetic algorithm for recombination detection

A scalable method for identifying recombinants from unaligned sequences

Improved Algorithmic Complexity for the 3SEQ Recombination 481 Detection Algorithm

Macromolecular modeling and design in Rosetta: recent methods and 483 frameworks

Paratope Structural Optimization during Antibody-Antigen

Docking Compensates for Errors in Antibody Homology Models

The FoldX web server: an online force field

CoV3D: a database of high resolution coronavirus protein structures